Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2005
05/18/2005CN1202134C Polysaccharide compound having immune stimulating activity
05/18/2005CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment
05/18/2005CN1202124C Artificial synthetic organic polypeptide compound and its use
05/18/2005CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202068C Aspirin-triggered lipid mediators
05/18/2005CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/18/2005CN1201805C Medicinal composition for reducing poison and synergic action in radiothrerapy or chemotherapy and its preparing method
05/18/2005CN1201732C Oral pharmaceutical forms of administration with a delayed action
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894168 Carbamoyl tetrahydropyridine derivatives
05/17/2005US6894165 Imidazonaphthyridines
05/17/2005US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
05/17/2005US6894067 5-heteroatom-substituted pyrazoles
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/17/2005US6894038 Administering an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for treating multiple sclerosis
05/17/2005US6894036 4-dedimethylaminotetracycline derivatives
05/17/2005US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
05/17/2005US6893867 Molecular switch for regulating mammalian gene expression
05/17/2005US6893843 Nucleic acids
05/17/2005US6893838 DADD, death activator death domain protein
05/17/2005US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
05/17/2005US6893642 Anticancer nutraceutical from spirulina
05/17/2005US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases
05/17/2005US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies
05/17/2005US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
05/17/2005CA2335492C Pyrrolo[2,3-d]pyrimidine compounds
05/17/2005CA2304987C Inhibition of an fgf-binding protein using ribozymes
05/17/2005CA2250549C Reverse transcriptase inhibitor
05/17/2005CA2126327C Amidino derivatives and their use as nitric oxide synthase inhibitors
05/12/2005WO2005042727A2 Methods of organ regeneration
05/12/2005WO2005042507A1 Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt
05/12/2005WO2005041983A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
05/12/2005WO2005016514A3 Combinatorial synthesis on support
05/12/2005WO2005009343A3 A1 adenosine receptor antogonists
05/12/2005WO2005007699A3 Human antibody molecules for il-13
05/12/2005WO2004101776A3 Novel uses of ppar modulators and professional apcs manipulated by the same
05/12/2005WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101769 CD40-interacting and TRAF-interacting proteins
05/12/2005US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101632 Treating inflammation of the skin or mucous membrane by topical administration of an anti-inflammatory amount of dimethicone in the absence of any other anti-inflammatory agent
05/12/2005US20050101627 Preparation of 1H-imidazo [4,5-C] quinolin-4 amines via novel 1h-imidazo [4,5-C] quinolin-4-cyano and 1h-imidazo [4,5-C] quinolin-4-carboxamide intermediates
05/12/2005US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101536 Modulation of angiogenesis
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101528 Substituted (e)-styryl benzylsulfones for treating proliferative disorders
05/12/2005US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100617 Method for improving age-related physiological deficits and increasing longevity
05/12/2005US20050100616 Administering plant extracts; health food; allergies
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050100551 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
05/12/2005US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050100534 firoin and firoin-A from extremophilic microorganisms ; active protection and stabilization of skin cells and their organic constituents (proteins, enzymes, membranes, nucleic acids or antioxidants); against damaging environmental influences, UV radiation.
05/12/2005CA2544731A1 Rapamycin peptides conjugates: synthesis and uses thereof
05/12/2005CA2544365A1 Modified anti-cd52 antibody
05/12/2005CA2544107A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
05/12/2005CA2543745A1 Methods of organ regeneration
05/12/2005CA2543093A1 Therapeutic regimens for baff antagonists
05/12/2005CA2543080A1 Compositions and methods for activating innate and allergic immunity
05/12/2005CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/12/2005CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors
05/11/2005EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses
05/11/2005EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold
05/11/2005EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
05/11/2005EP1529046A1 Substituted benzimidazole compounds
05/11/2005EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
05/11/2005EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris
05/11/2005EP1399127B1 Olopatadine formulations for topical administration
05/11/2005EP1397363B1 5-ethyl-imidazotriazinones
05/11/2005EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate
05/11/2005EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/11/2005EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
05/11/2005EP1248802B9 Soluble ctla4 mutant molecules and uses thereof
05/11/2005EP1214416B1 Use of replication-deficient adenoviral vector in the manufacture of a medicament to boost cd8+ t cell immune response to antigen
05/11/2005EP1076563B1 Dipeptide caspase inhibitors and the use thereof
05/11/2005EP0969815B1 Pharmaceutical compositions
05/11/2005EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins
05/11/2005EP0572478B1 Hbgad and higad polypeptides and nucleic acids and their use for the diagnosis and treatment of gad autoantigen associated diseases
05/11/2005CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor
05/11/2005CN1615368A Effectors of innate immunity
05/11/2005CN1615157A Compositions inhibiting rejection in organ transplantation and method of using the same
05/11/2005CN1615152A Method for reducing acne or improving skin tone
05/11/2005CN1615148A Methods and compositions for derepression of IAP-inhibited caspase
05/11/2005CN1615140A Polynucleotide therapy
05/11/2005CN1613872A Interferon of IFN-beta-cn and its mutant
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1172